TY - CHAP
T1 - Quality of life in patients with lung cancer
AU - DiGiovanni, Julia
AU - Popovic, Marko
AU - Chow, Edward
AU - Cella, David
AU - Beaumont, Jennifer L.
AU - Nguyen, Jasmine
AU - Chu, Dominic
AU - Adili, Anthony
AU - Pulenzas, Natalie
AU - Lechner, Breanne
AU - Lam, Henry
AU - Bottomley, Andrew
N1 - Publisher Copyright:
© 2016 Nova Science Publishers, Inc.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - In this chapter we compare the development, characteristics, validity and reliability of two widely used quality of life (QOL) assessment tools in lung cancer: the EORTC QLQLC13 and the FACT-L. The authors found that both questionnaires were developed from input of patients and health care professionals. The QLQ-LC13 is a 13-item instrument that assesses coughing, hemoptysis, dyspnea and pain and the side effects of treatment. Two international field studies have concluded that the QLQ-LC13 is clinically valid and useful. Conversely, the FACT-L assesses general QOL and seven lung cancer-specific items, such as shortness of breath, weight loss, cough, and appetite. In a study of 116 lung cancer patients, the FACT-L was found to have a good internal consistency, reliability, and sensitivity to changes in performance status. Ultimately, both the EORTC QLQ-LC13 and the FACT-L have been sufficiently validated; as such, decision-making should depend on the needs of the investigation.
AB - In this chapter we compare the development, characteristics, validity and reliability of two widely used quality of life (QOL) assessment tools in lung cancer: the EORTC QLQLC13 and the FACT-L. The authors found that both questionnaires were developed from input of patients and health care professionals. The QLQ-LC13 is a 13-item instrument that assesses coughing, hemoptysis, dyspnea and pain and the side effects of treatment. Two international field studies have concluded that the QLQ-LC13 is clinically valid and useful. Conversely, the FACT-L assesses general QOL and seven lung cancer-specific items, such as shortness of breath, weight loss, cough, and appetite. In a study of 116 lung cancer patients, the FACT-L was found to have a good internal consistency, reliability, and sensitivity to changes in performance status. Ultimately, both the EORTC QLQ-LC13 and the FACT-L have been sufficiently validated; as such, decision-making should depend on the needs of the investigation.
UR - http://www.scopus.com/inward/record.url?scp=85060483615&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060483615&partnerID=8YFLogxK
M3 - Chapter
AN - SCOPUS:85060483615
SN - 9781634838634
SP - 79
EP - 92
BT - Cancer
PB - Nova Science Publishers, Inc.
ER -
